ReviewRSC advances2025
2D materials for nutraceutical delivery and smart packaging: multifunctional, sustainable, and responsive applications.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Processed Meats as Delivery Systems for Nutraceuticals: Technological Advances, Bioavailability, Health Benefits, and Future Perspectives.Foods (Basel, Switzerland) · 2026Review
- Defect and interface engineering of visible-light-active semiconductor nanomaterials for sustainable photocatalytic pathogen inactivation.Nanoscale advances · 2026Review
- Antimicrobial nanomaterials at the nanoscale: design principles, mechanisms, and global challenges.Nanoscale advances · 2026Review
- Concept of 2D van der Waals Nanohybrids for Key Biomedical Applications.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Materials in the form of two-dimensional (2D) structures have recently become a revolutionary platform in nutraceutical delivery and smart food packaging, solving the problem of poor solubility, stability, and bioavailability of bioactive compounds. Traditional delivery systems are not always effective in preventing the degradation of sensitive nutraceuticals like polyphenols, flavonoids, vitamins, and probiotics in response to light, heat, pH changes, or enzyme activity, which reduces their therapeutic potential. Similarly, conventional packaging materials offer little protection and no active food freshness monitoring, which leads to shorter shelf life and poor quality. The novelty of this review is the focus on the multifunctional potential of 2D materials in improving nutraceutical delivery and allowing smart, antimicrobial packaging with targeted, responsive, and sustainable applications. In contrast to the existing reviews that mainly focus on biomedical or pharmaceutical applications, this review summarizes nutraceutical-specific advances, critically evaluates various 2D materials, including graphene and graphene derivatives, MXenes, layered double hydroxides (LDHs), transition metal dichalcogenides (TMDs), and 2D metal-organic frameworks (MOFs), and points out regulatory, toxicological, and sustainability issues that are essential to real-world translation. Recent reports indicate that 2D materials can be used to efficiently encapsulate bioactives and enhance solubility, chemical stability, and controlled or stimuli-responsive release. In addition, these materials offer antimicrobial, antioxidant and sensing properties to packaging, allowing real-time monitoring and extended shelf life. Collectively, these features turn traditional delivery and packaging into smart, multifunctional platforms. Although these developments have been made, there are still challenges such as the possibility of biosafety issues, lack of standard procedures, regulatory frameworks, and challenges of scalable production. The future outlook focuses on the development of safe, biodegradable, and commercially viable 2D materials, along with standardized evaluation platforms, to provide sustainable, effective, and market-ready nutraceutical delivery and smart packaging solutions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.